Radiation Oncology Market Intense Competition among Vendors to Increase Their Footprint by Adopting Business Strategies
Radiation oncology market in increasing in the 21st century, the frequency of cancer and the suffering often associated with it has significantly raised cancer awareness. Radiation therapy, along with the chemotherapy and surgery is used to treat cancer. It is estimated that radiation therapy is administered to 50% of all cancer patients. The discovery of X-rays and radioactivity leads to the development of the radiation treatment techniques.
Radiation oncology market is an increasingly popular specialty. With rising cancer rates and numerous advances in medical technology, the field offers tremendous opportunities for practice and research. Radiation oncologists use a variety of treatment methods, including radioactive implantations, external beam radiotherapy, hyperthermia and combined modality therapy such as radiotherapy and oncology with surgery, chemotherapy or immunotherapy.
The technology has advanced to the point where techniques can target tumor metabolism or oxygenation, leading to a more specific approach to cancer treatment than just focusing on anatomy. Imaging technology also allows the oncologist to see where tumors sit in a patient’s body and account for factors such as respiration and movement, resulting in greater precision in treatment delivery. Technological advancement will help cure patient’s physicians. Exposure to radiation has been worrisome for many people, but radiology oncology are rarely, if ever exposed.
Radiation oncology market, North America is the dominating one in the market, driven by class healthcare infrastructure, advanced facilities, higher awareness and with higher technological perception. Europe and Asia-Pacific are the other continents in the row of emergence. Asia-Pacific is expected in increasing rapidly due to growing population and increase in disease. China and India is the region developing regions of Asia-Pacific.
- Cancer Testing/Screening Market: By
Cancer Type (Lung, Blood, Bone, Others); By Technique (Imaging, Bio
Marker, Radiation, Others); By Product (Molecular & Companion
Testing); By Stage (Tnm, Prognostic Factors, Others); By Gender; By
Geography - (2015-2023)
- Enteral Feeding Formula Market:
By Product Type (Standard Formula & Disease Specific Formulas); By
Application (Oncology, Gastroenterology, Neurology, Critical Care &
Others); & By Region-Forecast (2017-2022)